The DNMTi decitabine, azacitidine and aza-T-dCyd were used in this in vitro and in vivo study, where all three DNMTi inhibited the expression of DNMT1, inhibited cell growth and induced cytotoxicity and/or apoptosis of colorectal cancer cells. This evidence concerns the gene DNMT1 and colorectal cancer.